About Us

Guangdong Hengqin Novagains Biotechnology Co., Ltd. is an AU-funded biopharmaceutical innovation company. Leveraging the strategic location of the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, we are dedicated to developing innovative drugs for the global market.

Xiangbei Wellman Pharmaceutical Co., Ltd. holds 75% of the company, while Macau investors hold 25%, leveraging regional strengths to drive biopharmaceutical innovation.

Mission

Science-Driven, Life-Forward

Vision

To become a global leader in innovative drug R&D

Values

Professionalism, Innovation, Collaboration, Responsibility

Milestones

2024

Company founded in the Hengqin Guangdong-Macao In-Depth Cooperation Zone

2025

F-02-2-Na received IND approval in China and the US

2025

Established a strategic partnership with the Macau University of Science and Technology

2026

Multiple innovative drug candidates entered the PCC stage

Honors and Qualifications

Enterprise Qualifications and Honors

Postdoctoral Program Plaque

Looking Forward to Your Partnership

Contact Us